Pfizer’s Wyeth Settles Effexor XR Antitrust Case for $39 Million
Pfizer subsidiary Wyeth has agreed to a $39 million settlement in a long-standing antitrust case related to its antidepressant drug…
Pfizer
U.S. Appeals Court Upholds Dismissal of Lawsuit Against Pfizer’s Diversity Program
In a recent ruling, the 2nd U.S. Circuit Court of Appeals in New York upheld the dismissal of a lawsuit…
Pfizer Settles Antitrust Claims for $93 Million
Background Pfizer (PFE.N) has agreed to a settlement of $93 million to resolve antitrust allegations brought forth by wholesale drug…
Pharmaceutical Giants Challenge Zantac Cancer Claims in Delaware Court
In a crucial legal battle, pharmaceutical companies, including GSK, Pfizer, and others, seek to convince a Delaware judge that the…
Former Arent Fox Patent and IP Partner Found Guilty of Insider Trading
Summary: A patent prosecution and intellectual property partner for Arent Fox was convicted in the insider trading of a pharmaceutical…
Pfizer Settles Class Action Suit for $486 Million
Summary: Pfizer has agreed to pay $486 million to settle a class action lawsuit with investors. After over a decade…
Beth Wilkinson Exits Biglaw to Form Boutique Firm
Famed litigator Beth Wilkinson left Paul, Weiss, Rifkind, Wharton & Garrison LLP to launch her own boutique with two other attorneys.…
Pfizer Acquires Allergan, Moves Headquarters to Ireland
Summary: With the acquisition of Allergan and their headquarters to be located outside the United States, Pfizer will escape paying…
Skadden Assumes Top Spot for M&A Deals in 2014
Summary: Skadden has moved back into the top spot for mergers and acquisitions in 2014 after finishing seventh in 2013. Skadden,…
Obama Calls Out Companies That Switch Addresses for Tax Purposes
When making remarks on Friday at a technical college in Los Angeles, President Barack Obama had some strong words for…
Supreme Court Set to Rule in Halliburton Class Action Case
The United States Supreme Court is expected to issue a ruling within the next two weeks in a case that…
Pfizer in Battle for Britain’s AstraZeneca
Pfizer, the U.S. big pharma drugmaker is trying to secure its next move with its $100 billion fight for Britain's…